前沿科技 OpenAI 与美国 FDA 讨论使用 AI 进行药物评估 by 《亚太新闻周刊》 1 min read FDA 的目标是使用 AI 缩短审查时间,同时保持安全性和有效性。 Share This Facebook X Telegram Whatsapp Email Tags FDAOpenAI与美国讨论使用进行药物评估 Related Posts OpenAI said to cut Microsoft, partners revenue share to 8% 3 天 ago OpenAI opens Korean office to deepen AI partnerships 5 天 ago OpenAI 的印度问候隐藏了风险 1 周 ago 《亚太新闻周刊》 发表回复 取消回复Your email address will not be published. 在此浏览器中保存我的显示名称、邮箱地址和网站地址,以便下次评论时使用。 搜索搜索Recent PostsThese airports were ranked the best in North America. Here's why. Developments in major legal cases including Kirk suspect, Mangione and Menendez brothers FBI director Kash Patel grilled by senators over Kirk assassination, Epstein files Agoda cuts 50 employees over cost, hiring challenges Prices range from $3,000 to $14,680. CategoriesCategories 选择分类 Breaking News 亚洲要闻 人物评选 企业评选 健康生活 前沿科技 医学医疗 医疗 品牌评选 商业 政治与社会 最新 评选申报 财经 财经商业 金融投资 Latest from Blog These airports were ranked the best in North America. Here's why. by 《亚太新闻周刊》 Developments in major legal cases including Kirk suspect, Mangione and Menendez brothers by 《亚太新闻周刊》 FBI director Kash Patel grilled by senators over Kirk assassination, Epstein files by 《亚太新闻周刊》 Agoda cuts 50 employees over cost, hiring challenges by 《亚太新闻周刊》 Prices range from $3,000 to $14,680. by 《亚太新闻周刊》 Private equity loves K-beauty by 《亚太新闻周刊》 IHH SG hospitals will participate under the new contract. by 《亚太新闻周刊》 Equity in Healthcare: Turning Innovation into Impact from Southeast Asia by 《亚太新闻周刊》 Chinese tech stocks soar as index hits highest since 2021 by 《亚太新闻周刊》 Indian consumer electronics firm Indkal raises $20m series B by 《亚太新闻周刊》